Cheuk Kee Candy Fung

Dr. Cheuk Kee Candy Fung

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
CFCheuk Kee Candy Fung
Cheuk Kee Candy Fung
DHDiep Ha
Diep Ha
Laurence James WalshLaurence James Walsh
Laurence James Walsh
CSClaudia Patricia LOPEZ SILVA
Claudia Patricia LOPEZ SILVA
Background/Objectives: Unmet oral health needs of residents in residential aged care facilities (RACFs) arise due to the unique challenges of assessing oral health statuses and maintaining oral healthcare in RACFs. This pilot study assessed the feasibility of using real-time teledentistry under the guidance of a dentist to train RACF staff to undertake an oral health assessment. Methods: An oral health assessment of residents was first conducted by RACF staff at two Queensland, Australia RACFs using the Oral Health Assessment Tool, with an intra-oral camera connected to a laptop, through videoconferencing, under the guidance of a dentist. A survey recorded the views of RACF staff on the acceptability of the teledentistry method. The quality of the images obtained through the camera was assessed by the dentist. Finally, cost-effectiveness was calculated between teledentistry and traditional face-to-face assessments. Results: Sixteen residents (mean age 79.3 ± 8.68 years) and eight staff (mean age 33.3 ± 6.16 years) participated in this study. Both RACF staff and residents found that the real-time teledentistry set-up was user-friendly, while the dentist rated the quality of the images as acceptable for diagnostic purposes. Real-time teledentistry was more cost-effective than bringing a dentist on-site, while taking the RACF residents to an off-site dental office for examination was the most expensive approach. Conclusions: Real-time teledentistry is feasible and cost-effective, and it is an acceptable alternative to a face-to-face clinical exam for oral health assessment in RACFs. This approach could be used in RACFs where wireless internet connectivity is available.

22 May 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
DHDiep Ha
Diep Ha
LSLydia See
Lydia See
CSClaudia Patricia LOPEZ SILVA
Claudia Patricia LOPEZ SILVA
HSHelena Silveira Schuch
Helena Silveira Schuch
CFCheuk Kee Candy Fung
Cheuk Kee Candy Fung
LDLoc Do
Loc Do
Background: Older adults living in residential aged care facilities (RACFs), particularly in regional and rural areas, experience a high burden of untreated dental caries, tooth sensitivity, and oral pain. Workforce shortages, limited access to dental services, and competing health priorities make the delivery of timely oral health care challenging in these settings. Poor oral health contributes to pain, impaired nutrition, reduced quality of life, and increased health service use. There is an urgent need for context-appropriate, accessible, and cost-effective interventions for RACF residents. Aqueous silver fluoride (AgF), a minimally invasive topical agent with caries-arresting and desensitizing properties, offers a pragmatic approach suitable for aged care settings. Objective: This protocol aims to test the effectiveness of an AgF intervention package in reducing tooth sensitivity and tooth pain, arresting caries, and improving oral health and well-being in older adults living in regional and rural RACFs. Methods: This study is a 2-arm, parallel-group cluster randomized controlled trial, with RACFs as the unit of randomization. The trial is conducted in public and private RACFs across regional and rural Queensland and New South Wales, Australia. Eligible participants are residents with at least 1 natural tooth. At baseline, calibrated examiners perform standardized oral examinations to assess dental caries status, lesion activity, and dentin hypersensitivity. AgF is applied to eligible carious lesions and sensitive tooth surfaces following a standardized clinical protocol. Follow-up assessments at 3 months include a repeat clinical examination to assess caries arrest and changes in hypersensitivity, along with resident-reported measures of oral pain and oral health–related quality of life collected using validated instruments. Outcomes include change in tooth sensitivity and oral pain at the 3-month follow-up, caries arrest rates, and change in oral health–related quality of life. Analyses will follow intention-to-treat principles and account for clustering using mixed-effects regression models with facility-level random effects. Models will adjust for baseline covariates and prespecified confounders. Sensitivity analyses will examine the robustness of the findings. The trial will also inform a planned economic evaluation embedded within the broader research program. Results: This trial forms part of a broader program funded by the Medical Research Future Fund Dementia, Aging and Aged Care Grant (2024439). Recruitment and data collection commenced in May 2025 and are expected to conclude in June 2026. Recruitment is ongoing across participating RACFs. Data analysis is expected to commence in mid-2026, with primary findings anticipated for publication in early 2027. Conclusions: This protocol outlines a rigorous evaluation of a minimally invasive, scalable oral health intervention tailored to RACF settings. The findings will provide high-quality evidence on effectiveness to inform policy, service delivery, and economic evaluation aimed at improving oral health and well-being among older adults in residential aged care.

27 November 2025 in JMIR Preprints
Verified
Preprint
Open access
DHDiep Ha
Diep Ha
LSLydia See
Lydia See
CSClaudia Patricia LOPEZ SILVA
Claudia Patricia LOPEZ SILVA
HSHelena Silveira Schuch
Helena Silveira Schuch
CFCheuk Kee Candy Fung
Cheuk Kee Candy Fung
LDLoc Do
Loc Do
BACKGROUND There are specific challenges in identifying and delivering effective treatments which can protect and improve oral health in residential aged care facilities (RACFs). This is especially the case in those living in regional and rural areas. Given the consequences of poor oral health for older people living in RACFs, there is an urgent need for high-quality evidence on oral health interventions that are appropriate to context and need, accessible, and cost-effective for aged care residents. Applying aqueous forms of silver fluoride (AgF) can be effective and suitable for improving this population’s oral health and wellbeing. OBJECTIVE This paper outlines a research protocol which aims to test the effectiveness of an AgF intervention package in reducing tooth sensitivity, tooth pain, arresting caries, and improving oral health and wellbeing in older adults living in regional and rural RACFs. METHODS This study protocol describes a cluster randomised controlled trial with two parallel arms. The control arm will receive delayed intervention after 3-months. This approach allows for all participants to receive an oral examination and access to AgF treatment by the end of the study. Study sites include RACFs in public and private sectors across rural and regional Queensland and New South Wales, Australia. Oral assessments will be undertaken for RACF residents who provided consent, with at least one natural tooth. Teeth will be assessed for eligibility to receive AgF treatment. Outcomes at the 3-month follow-up will be collected through survey and clinical examination and include tooth sensitivity and pain, dental caries and oral health-related quality of life. RESULTS This clinical study is part of an overarching project funded by the MRFF Dementia Ageing and Aged Care Grant #2024439. Data collection commenced in May 2025 for the cluster randomized controlled trial and is anticipated to continue until March 2026. CONCLUSIONS This research protocol will provide a rigorous test of the efficacy of a minimally invasive intervention package of AgF to improve the oral health and wellbeing of older adults in RACFs. CLINICALTRIAL This clinical trial has been registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12625000072415: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12625000072415